Research
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
NEJM ·
The Brief
- The New England Journal of Medicine published a letter titled "Perioperative Apalutamide in High-Risk Localized Prostate Cancer".
- The item appears in volume 395, issue 19, pages 1965-1968, with an issue date of November 12, 2026.
- The available source is only the listing page and gives no further trial data or results.
Why it matters
Clinicians and readers following prostate cancer treatment can use this NEJM item to locate the report on perioperative apalutamide in high-risk localized disease; the source itself does not describe its findings.
Who’s affected
- urologists and oncologists
- prostate cancer patients and their families
- #prostate cancer
- #apalutamide
- #oncology
- #urology
- #perioperative therapy
New England Journal of Medicine, Volume 395, Issue 19 , Page 1965-1968, November 12, 2026.
Timeline
Published online on nejm.org
nejm.org
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Appears in NEJM volume 395, issue 19, pages 1965-1968